BRD4 and neoplasm: In conclusion, our study not only reveals a novel enhancer-mediated transcriptional mechanism involving NR2F2 and BRD4 that activates BGN in PTC but also highlights BGN's dual role in promoting tumor cell-intrinsic aggressiveness and shaping the tumor immune environment.